At present, NRx Pharmaceuticals Inc. (NRXP) has a stock price of $0.26. In the previous session, the stock saw a rise, peaking at $0.28 after an opening price of $0.2781. The day’s lowest price was $0.255, and it closed at $0.28.
NRx Pharmaceuticals Inc. ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $1.54 on 11/29/22, while the lowest value for the same period was recorded at $0.22 on 09/08/23.
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free
52-week price history of NRXP Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. NRx Pharmaceuticals Inc.’s current trading price is -83.29% away from its 52-week high, while its distance from the 52-week low is 16.43%. The stock’s price range during this period has spanned from $0.22 to $1.54. In the Healthcare sector, the NRx Pharmaceuticals Inc.’s shares surpassed a trading volume of approximately 1.08 million for the day, which was noticeably lower compared to the average daily volume of 9.1.35 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
NRx Pharmaceuticals Inc. (NRXP) has experienced a quarterly decline of -50.52% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 19.41M and boasts a workforce of 2 employees.
A Closer Look at Analysts’ Ratings for NRx Pharmaceuticals Inc.
As of right now, 2 analysts are rating NRx Pharmaceuticals Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4627, with a change in price of -0.3566. Similarly, NRx Pharmaceuticals Inc. recorded 1,006,820 in trading volume during the last 100 days, posting a change of -58.09%.
NRXP Stock Stochastic Average
Today’s raw stochastic average for NRx Pharmaceuticals Inc. over the last 50 days is 14.58%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 25.21%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 31.94% and 29.46%, respectively.
NRXP Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -76.82%.However, over the last six months, we can see a stronger performance of -63.74%. Over the last 30 days, the price of NRXP has leaped by -23.19%. And in the last five days, it has fallen by -1.79%.
